{
  "id": "plexopathy",
  "title": "Plexopathy - Brachial and Lumbosacral",
  "version": "1.1",
  "icd10": [
    "** G54.0 (Brachial plexus disorders)",
    "G54.1 (Lumbosacral plexus disorders)",
    "G54.5 (Neuralgic amyotrophy / Parsonage-Turner syndrome)",
    "G54.9 (Nerve root and plexus disorder",
    "unspecified)",
    "G62.0 (Drug-induced polyneuropathy",
    "radiation plexopathy)",
    "C47.1 (Malignant neoplasm of peripheral nerves of upper limb",
    "including shoulder)",
    "C47.2 (Malignant neoplasm of peripheral nerves of lower limb",
    "including hip)",
    "G63 (Polyneuropathy in diseases classified elsewhere)",
    "E11.44 (Type 2 diabetes with diabetic amyotrophy)"
  ],
  "scope": "** Evaluation and management of brachial and lumbosacral plexopathy in adults. Covers idiopathic/inflammatory (Parsonage-Turner syndrome / neuralgic amyotrophy), traumatic, compressive, radiation-induced, diabetic (diabetic amyotrophy / DLRPN), and neoplastic etiologies. Includes diagnostic workup with MRI plexus imaging, EMG/NCS, and laboratory evaluation. Addresses acute pain management, immunotherapy for inflammatory etiologies, rehabilitation, and surgical considerations. Excludes isolated mononeuropathies (see Carpal Tunnel Syndrome, Peroneal Neuropathy templates), cervical/lumbar radiculopathy (see Radiculopathy template), and brachial plexus birth injuries.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC with differential (CPT 85025)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Infection screen; malignancy screen; assess for leukocytosis or anemia",
          "target": "Normal WBC; no anemia; no atypical cells"
        },
        {
          "item": "CMP - BMP + LFTs (CPT 80053)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Baseline renal/hepatic function for medications; electrolytes; glucose",
          "target": "Normal electrolytes; normal glucose"
        },
        {
          "item": "HbA1c (CPT 83036)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Diabetes is major cause of lumbosacral plexopathy (diabetic amyotrophy); may be initial presentation",
          "target": "<5.7%; elevated suggests diabetic amyotrophy"
        },
        {
          "item": "ESR (CPT 85652)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Elevated in inflammatory, neoplastic, and infectious etiologies",
          "target": "<20 mm/hr (age-adjusted)"
        },
        {
          "item": "CRP (CPT 86140)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Acute-phase reactant for inflammatory and infectious causes",
          "target": "<0.5 mg/dL"
        },
        {
          "item": "Fasting glucose (CPT 82947)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Screen for diabetes; diabetic amyotrophy may present in pre-diabetes",
          "target": "<100 mg/dL"
        }
      ],
      "Extended Workup (Second-line)": [
        {
          "item": "TSH (CPT 84443)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Thyroid disease can cause myopathy and neuropathy; confounding factor",
          "target": "Normal (0.4-4.0 mIU/L)"
        },
        {
          "item": "Vitamin B12 (CPT 82607)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "B12 deficiency causes neuropathy that may overlap with plexopathy",
          "target": ">300 pg/mL"
        },
        {
          "item": "ANA (CPT 86038)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Connective tissue disease associated with vasculitic plexopathy",
          "target": "Negative or low titer"
        },
        {
          "item": "ANCA panel (CPT 86200, 86235)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis) causing plexopathy",
          "target": "Negative"
        },
        {
          "item": "SPEP with immunofixation (CPT 84165, 86334, 86335)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Paraproteinemia; lymphoma; amyloidosis causing plexopathy",
          "target": "No M-spike; no monoclonal band"
        },
        {
          "item": "Coagulation panel - PT/INR, PTT (CPT 85610, 85730)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "If retroperitoneal hematoma suspected; pre-procedural assessment",
          "target": "INR <1.5; PTT normal"
        },
        {
          "item": "LDH (CPT 83615)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Elevated in lymphoma and other malignancies",
          "target": "Normal (120-246 U/L)"
        },
        {
          "item": "Uric acid (CPT 84550)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Tumor lysis; gout causing nerve compression (rare)",
          "target": "Normal (3.5-7.2 mg/dL)"
        },
        {
          "item": "Urinalysis (CPT 81001)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "UTI as confounding factor; proteinuria in vasculitis",
          "target": "Normal"
        }
      ],
      "Rare/Specialized (Refractory or Atypical)": [
        {
          "item": "CSF analysis (CPT 89050, 89051)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Elevated protein in DLRPN/diabetic amyotrophy and neoplastic plexopathy; cytology for leptomeningeal disease",
          "target": "Protein <45 mg/dL; no malignant cells; normal cell count"
        },
        {
          "item": "Paraneoplastic panel (CPT 86255)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Paraneoplastic plexopathy (anti-Hu, anti-CV2/CRMP5); subacute progressive course with occult malignancy",
          "target": "Negative"
        },
        {
          "item": "Ganglioside antibodies - GM1, GD1a, GD1b (CPT 86255)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Multifocal motor neuropathy mimicking plexopathy; GBS variants",
          "target": "Negative"
        },
        {
          "item": "Anti-LRP4 antibodies (CPT 86235)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Associated with hereditary neuralgic amyotrophy (SEPT9 mutation); research use",
          "target": "Negative"
        },
        {
          "item": "Lyme serology (CPT 86618)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Endemic areas; Lyme can cause polyradiculoplexopathy",
          "target": "Negative"
        },
        {
          "item": "ACE level (CPT 82164)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Sarcoidosis with multifocal neuropathy/plexopathy",
          "target": "Normal"
        },
        {
          "item": "HIV serology (CPT 86703)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "HIV-associated plexopathy; CMV polyradiculopathy in immunocompromised",
          "target": "Negative"
        },
        {
          "item": "Cryoglobulins (CPT 86157)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Cryoglobulinemic vasculitis causing plexopathy",
          "target": "Negative"
        },
        {
          "item": "Genetic testing - SEPT9 gene (CPT 81479)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Hereditary neuralgic amyotrophy (recurrent episodes, family history)",
          "target": "No pathogenic variant"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "MRI brachial plexus with and without contrast (CPT 73221)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "STAT if mass suspected; within 1 week for inflammatory/traumatic",
          "target": "Nerve T2 hyperintensity; muscle denervation edema; enhancing mass; nerve enlargement",
          "contraindications": "MRI-incompatible pacemaker; cochlear implant; GFR <30 for gadolinium"
        },
        {
          "item": "MRI lumbosacral plexus with and without contrast (CPT 72197)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "STAT if mass suspected or retroperitoneal hematoma; within 1 week otherwise",
          "target": "Nerve enhancement; mass lesion; psoas hematoma; diffuse vs. focal nerve signal abnormality",
          "contraindications": "MRI-incompatible device; GFR <30 for gadolinium; claustrophobia"
        },
        {
          "item": "MRI lumbar spine without contrast (CPT 72148)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "Concurrent with plexus imaging to exclude radiculopathy",
          "target": "Disc herniation; foraminal stenosis; conus/cauda equina lesion",
          "contraindications": "MRI-incompatible device"
        },
        {
          "item": "MRI cervical spine without contrast (CPT 72141)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "If brachial plexopathy - exclude cervical radiculopathy",
          "target": "Disc herniation; foraminal stenosis; cord lesion",
          "contraindications": "MRI-incompatible device"
        },
        {
          "item": "EMG/NCS - electrodiagnostic studies (CPT 95886, 95909)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Optimal at 3-4 weeks after symptom onset; can perform earlier for baseline",
          "target": "Denervation in plexus distribution crossing multiple nerve territories; myokymic discharges (radiation); conduction block (compression)",
          "contraindications": "Anticoagulation (relative for needle EMG); pacemaker (relative)"
        }
      ],
      "Extended": [
        {
          "item": "CT chest with contrast (CPT 71260)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "If Pancoast tumor suspected (lower trunk brachial plexopathy + Horner)",
          "target": "Lung apex mass; mediastinal lymphadenopathy",
          "contraindications": "Contrast allergy; renal insufficiency (GFR <30)"
        },
        {
          "item": "CT abdomen/pelvis with contrast (CPT 74178)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "timing": "If retroperitoneal hematoma suspected; pelvic mass",
          "target": "Retroperitoneal hematoma; pelvic mass compressing lumbosacral plexus",
          "contraindications": "Contrast allergy; renal insufficiency"
        },
        {
          "item": "CT angiography - upper extremity (CPT 73206) or lower extremity (CPT 73706)",
          "ED": "STAT",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "STAT",
          "timing": "Post-traumatic plexopathy to assess vascular injury",
          "target": "Vascular compromise; pseudoaneurysm; arteriovenous fistula",
          "contraindications": "Contrast allergy; renal insufficiency"
        },
        {
          "item": "Ultrasound - nerve (CPT 76881, 76882)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Real-time assessment of nerve continuity; guide injection",
          "target": "Nerve enlargement; loss of fascicular pattern; mass",
          "contraindications": "None significant"
        },
        {
          "item": "PET-CT (CPT 78816)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Differentiate radiation plexopathy from tumor recurrence; occult malignancy",
          "target": "FDG-avid mass suggests tumor recurrence; diffuse uptake may be inflammatory",
          "contraindications": "Pregnancy; uncontrolled diabetes"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "MR neurography - dedicated plexus protocol (CPT 73221)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "High-resolution nerve imaging when standard MRI equivocal",
          "target": "Fascicular detail; intraneural pathology; nerve continuity assessment",
          "contraindications": "MRI-incompatible device; GFR <30"
        },
        {
          "item": "Nerve biopsy - typically sural or superficial peroneal (CPT 64795)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Vasculitis suspected; amyloidosis; sarcoidosis; diagnosis uncertain after non-invasive workup",
          "target": "Vasculitis (necrotizing); amyloid deposits; granulomas; perivascular inflammation",
          "contraindications": "Coagulopathy; patient preference"
        },
        {
          "item": "Muscle biopsy (CPT 20206)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "If concurrent myopathy suspected; vasculitic neuropathy confirmation",
          "target": "Neurogenic atrophy pattern; perifascicular atrophy (if myopathy); vasculitis",
          "contraindications": "Coagulopathy; infection at site"
        },
        {
          "item": "Bone scan (CPT 78300)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Suspected skeletal metastasis causing plexus compression",
          "target": "No increased uptake at plexus level",
          "contraindications": "Pregnancy"
        },
        {
          "item": "SSEP - somatosensory evoked potentials (CPT 95925, 95926)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Pre-ganglionic vs. post-ganglionic lesion localization (traumatic)",
          "target": "Absent cortical response with preserved SNAPs suggests pre-ganglionic (root avulsion)",
          "contraindications": "None significant"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "Methylprednisolone (CPT 96365, 96366)",
          "route": "IV",
          "indication": "Severe acute inflammatory plexopathy (neuralgic amyotrophy with progressive weakness); neoplastic plexopathy with impending cord/nerve compromise",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg daily",
                "orderSentence": "Methylprednisolone 500 mg IV daily"
              },
              {
                "text": "1000 mg daily",
                "orderSentence": "Methylprednisolone 1000 mg IV daily"
              },
              {
                "text": "1 g daily x3-5 days",
                "orderSentence": "Methylprednisolone 1 g IV daily x3-5 days"
              }
            ],
            "route": "IV",
            "instructions": "1000 mg IV daily x 3-5 days then transition to oral prednisone taper",
            "orderSentence": "Methylprednisolone 500 mg IV daily"
          },
          "contraindications": "Active infection; uncontrolled diabetes; GI bleeding; psychosis",
          "monitoring": "Glucose q6h; BP; psychiatric effects; GI prophylaxis",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Dexamethasone (CPT 96374 when IV)",
          "route": "IV/PO",
          "indication": "Acute plexopathy with severe pain and inflammation; peritumoral edema",
          "dosing": {
            "doseOptions": [
              {
                "text": "4 mg q6h",
                "orderSentence": "Dexamethasone 4 mg IV q6h"
              },
              {
                "text": "10 mg once then 4 mg q6h",
                "orderSentence": "Dexamethasone 10 mg IV once then 4 mg q6h"
              },
              {
                "text": "16 mg daily",
                "orderSentence": "Dexamethasone 16 mg IV daily"
              }
            ],
            "route": "IV",
            "instructions": "10 mg IV loading dose, then 4 mg IV/PO q6h; taper over 7-14 days",
            "orderSentence": "Dexamethasone 4 mg IV q6h"
          },
          "contraindications": "Active infection; uncontrolled diabetes; GI bleeding",
          "monitoring": "Glucose; BP; psychiatric effects; insomnia",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Prednisone",
          "route": "PO",
          "indication": "Acute inflammatory plexopathy (Parsonage-Turner); diabetic amyotrophy (controversial)",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg daily",
                "orderSentence": "Prednisone 5 mg PO daily"
              },
              {
                "text": "10 mg daily",
                "orderSentence": "Prednisone 10 mg PO daily"
              },
              {
                "text": "20 mg daily",
                "orderSentence": "Prednisone 20 mg PO daily"
              },
              {
                "text": "40 mg daily",
                "orderSentence": "Prednisone 40 mg PO daily"
              },
              {
                "text": "60 mg daily",
                "orderSentence": "Prednisone 60 mg PO daily"
              },
              {
                "text": "1 mg/kg daily",
                "orderSentence": "Prednisone 1 mg/kg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "60 mg PO daily x 5-7 days then taper over 2-4 weeks; total course 4-6 weeks for inflammatory etiology",
            "orderSentence": "Prednisone 5 mg PO daily"
          },
          "contraindications": "Active GI bleed; uncontrolled DM; active infection",
          "monitoring": "Glucose; BP; mood; weight; bone density if prolonged",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ketorolac (CPT 96374 when IV)",
          "route": "IV/IM",
          "indication": "Acute severe plexopathy pain (short-term)",
          "dosing": {
            "doseOptions": [
              {
                "text": "30 mg",
                "orderSentence": "Ketorolac (CPT 96374 when IV) 30 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "30 mg IV/IM q6h; max 5 days; reduce to 15 mg if elderly or renal impairment",
            "orderSentence": "Ketorolac (CPT 96374 when IV) 30 mg IV"
          },
          "contraindications": "CrCl <30; active GI bleed; aspirin allergy; post-CABG",
          "monitoring": "Renal function; GI bleeding",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Morphine (CPT 96374)",
          "route": "IV",
          "indication": "Severe acute plexopathy pain unresponsive to non-opioids",
          "dosing": {
            "doseOptions": [
              {
                "text": "15 mg q4h PRN",
                "orderSentence": "Morphine 15 mg IV q4h PRN"
              },
              {
                "text": "30 mg q4h PRN",
                "orderSentence": "Morphine 30 mg IV q4h PRN"
              },
              {
                "text": "2 mg q4h PRN",
                "orderSentence": "Morphine 2 mg IV q4h PRN"
              },
              {
                "text": "4 mg q4h PRN",
                "orderSentence": "Morphine 4 mg IV q4h PRN"
              }
            ],
            "route": "IV",
            "instructions": "2-4 mg IV q2-4h PRN severe pain; titrate to effect",
            "orderSentence": "Morphine 15 mg IV q4h PRN"
          },
          "contraindications": "Respiratory depression; severe asthma; paralytic ileus",
          "monitoring": "Respiratory status; sedation; pain scores",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Hydromorphone (CPT 96374)",
          "route": "IV",
          "indication": "Severe acute plexopathy pain (alternative to morphine)",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5-1 mg",
                "orderSentence": "Hydromorphone (CPT 96374) 0.5-1 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "0.5-1 mg IV q2-4h PRN; titrate to effect",
            "orderSentence": "Hydromorphone (CPT 96374) 0.5-1 mg IV"
          },
          "contraindications": "Respiratory depression; severe asthma; paralytic ileus",
          "monitoring": "Respiratory status; sedation; pain scores",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "Symptomatic Treatments - Pain Management": [
        {
          "item": "Gabapentin",
          "route": "PO",
          "indication": "Neuropathic pain from plexopathy (first-line)",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg TID",
                "orderSentence": "Gabapentin 100 mg PO TID"
              },
              {
                "text": "300 mg TID",
                "orderSentence": "Gabapentin 300 mg PO TID"
              },
              {
                "text": "600 mg TID",
                "orderSentence": "Gabapentin 600 mg PO TID"
              },
              {
                "text": "900 mg TID",
                "orderSentence": "Gabapentin 900 mg PO TID"
              },
              {
                "text": "1200 mg TID",
                "orderSentence": "Gabapentin 1200 mg PO TID"
              }
            ],
            "route": "PO",
            "instructions": "Start 300 mg qHS; increase by 300 mg q1-3 days; target 900-1800 mg TID; max 3600 mg/day",
            "orderSentence": "Gabapentin 100 mg PO TID"
          },
          "contraindications": "Renal impairment (adjust: CrCl 30-59 max 1400 mg/day; CrCl 15-29 max 600 mg/day; CrCl <15 max 300 mg/day)",
          "monitoring": "Sedation; dizziness; edema; taper to discontinue",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Pregabalin",
          "route": "PO",
          "indication": "Neuropathic pain from plexopathy (first-line alternative)",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg TID",
                "orderSentence": "Pregabalin 50 mg PO TID"
              },
              {
                "text": "75 mg BID",
                "orderSentence": "Pregabalin 75 mg PO BID"
              },
              {
                "text": "100 mg TID",
                "orderSentence": "Pregabalin 100 mg PO TID"
              },
              {
                "text": "150 mg BID",
                "orderSentence": "Pregabalin 150 mg PO BID"
              },
              {
                "text": "200 mg BID",
                "orderSentence": "Pregabalin 200 mg PO BID"
              },
              {
                "text": "300 mg BID",
                "orderSentence": "Pregabalin 300 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID (600 mg/day)",
            "orderSentence": "Pregabalin 50 mg PO TID"
          },
          "contraindications": "Renal impairment (adjust per CrCl); Class V controlled",
          "monitoring": "Sedation; weight gain; edema; dizziness",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Duloxetine",
          "route": "PO",
          "indication": "Neuropathic pain with depression/anxiety; diabetic amyotrophy pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "30 mg daily",
                "orderSentence": "Duloxetine 30 mg PO daily"
              },
              {
                "text": "60 mg daily",
                "orderSentence": "Duloxetine 60 mg PO daily"
              },
              {
                "text": "90 mg daily",
                "orderSentence": "Duloxetine 90 mg PO daily"
              },
              {
                "text": "120 mg daily",
                "orderSentence": "Duloxetine 120 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day",
            "orderSentence": "Duloxetine 30 mg PO daily"
          },
          "contraindications": "Hepatic impairment; CrCl <30; MAOIs; narrow-angle glaucoma",
          "monitoring": "Nausea; BP; discontinuation syndrome (taper over 2+ weeks)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Amitriptyline",
          "route": "PO",
          "indication": "Neuropathic pain (second-line; helps with sleep disruption from pain)",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg QHS",
                "orderSentence": "Amitriptyline 10 mg PO QHS"
              },
              {
                "text": "25 mg QHS",
                "orderSentence": "Amitriptyline 25 mg PO QHS"
              },
              {
                "text": "50 mg QHS",
                "orderSentence": "Amitriptyline 50 mg PO QHS"
              },
              {
                "text": "75 mg QHS",
                "orderSentence": "Amitriptyline 75 mg PO QHS"
              },
              {
                "text": "100 mg QHS",
                "orderSentence": "Amitriptyline 100 mg PO QHS"
              }
            ],
            "route": "PO",
            "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
            "orderSentence": "Amitriptyline 10 mg PO QHS"
          },
          "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly (anticholinergic)",
          "monitoring": "ECG if dose >100 mg/day; anticholinergic effects; sedation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Nortriptyline",
          "route": "PO",
          "indication": "Neuropathic pain (second-line; less sedating than amitriptyline)",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg QHS",
                "orderSentence": "Nortriptyline 10 mg PO QHS"
              },
              {
                "text": "25 mg QHS",
                "orderSentence": "Nortriptyline 25 mg PO QHS"
              },
              {
                "text": "50 mg QHS",
                "orderSentence": "Nortriptyline 50 mg PO QHS"
              },
              {
                "text": "75 mg QHS",
                "orderSentence": "Nortriptyline 75 mg PO QHS"
              },
              {
                "text": "100 mg QHS",
                "orderSentence": "Nortriptyline 100 mg PO QHS"
              }
            ],
            "route": "PO",
            "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
            "orderSentence": "Nortriptyline 10 mg PO QHS"
          },
          "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma",
          "monitoring": "ECG if dose >100 mg/day; fewer anticholinergic effects",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ibuprofen",
          "route": "PO",
          "indication": "Mild-moderate plexopathy pain; anti-inflammatory (adjunct)",
          "dosing": {
            "doseOptions": [
              {
                "text": "400 mg",
                "orderSentence": "Ibuprofen 400 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "400-800 mg TID with food; max 3200 mg/day; short-term use preferred",
            "orderSentence": "Ibuprofen 400 mg PO"
          },
          "contraindications": "CrCl <30; active GI bleed; aspirin allergy; third trimester pregnancy",
          "monitoring": "GI symptoms; renal function with prolonged use",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Naproxen",
          "route": "PO",
          "indication": "Mild-moderate plexopathy pain (longer duration NSAID)",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mg",
                "orderSentence": "Naproxen 250 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "250-500 mg BID with food; max 1500 mg/day",
            "orderSentence": "Naproxen 250 mg PO"
          },
          "contraindications": "CrCl <30; active GI bleed; aspirin allergy; third trimester pregnancy",
          "monitoring": "GI symptoms; renal function with prolonged use",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Acetaminophen",
          "route": "PO",
          "indication": "Mild pain (adjunct; avoid hepatotoxicity)",
          "dosing": {
            "doseOptions": [
              {
                "text": "650 mg",
                "orderSentence": "Acetaminophen 650 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "650-1000 mg q6h; max 3000 mg/day (2000 mg/day if liver disease)",
            "orderSentence": "Acetaminophen 650 mg PO"
          },
          "contraindications": "Severe hepatic impairment; chronic alcohol use",
          "monitoring": "LFTs with prolonged use",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Lidocaine patch 5%",
          "route": "TOP",
          "indication": "Localized plexopathy pain (shoulder, hip region)",
          "dosing": {
            "doseOptions": [
              {
                "text": "1-3 patches",
                "orderSentence": "Lidocaine patch 5% 1-3 patches TOP"
              }
            ],
            "route": "TOP",
            "instructions": "Apply 1-3 patches to affected area for 12h on, 12h off",
            "orderSentence": "Lidocaine patch 5% 1-3 patches TOP"
          },
          "contraindications": "Severe hepatic impairment; broken skin",
          "monitoring": "Minimal systemic absorption; local skin irritation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Capsaicin cream 0.075%",
          "route": "TOP",
          "indication": "Localized neuropathic pain (adjunct)",
          "dosing": {
            "doseOptions": [
              {
                "text": "Apply thin layer",
                "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
              }
            ],
            "route": "TOP",
            "instructions": "Apply TID-QID to affected area; takes 2-4 weeks for effect",
            "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
          },
          "contraindications": "Open wounds; avoid eyes/mucous membranes",
          "monitoring": "Initial burning (decreases with use); wash hands after",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Cyclobenzaprine",
          "route": "PO",
          "indication": "Muscle spasm associated with plexopathy (short-term)",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg TID",
                "orderSentence": "Cyclobenzaprine 5 mg PO TID"
              },
              {
                "text": "10 mg TID",
                "orderSentence": "Cyclobenzaprine 10 mg PO TID"
              }
            ],
            "route": "PO",
            "instructions": "5-10 mg TID; max 30 mg/day; limit to 2-3 weeks",
            "orderSentence": "Cyclobenzaprine 5 mg PO TID"
          },
          "contraindications": "Arrhythmia; heart failure; MAOIs within 14 days; hyperthyroidism",
          "monitoring": "Sedation; anticholinergic effects; dry mouth",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Baclofen",
          "route": "PO",
          "indication": "Muscle spasm refractory to cyclobenzaprine",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg TID",
                "orderSentence": "Baclofen 5 mg PO TID"
              },
              {
                "text": "10 mg TID",
                "orderSentence": "Baclofen 10 mg PO TID"
              },
              {
                "text": "20 mg TID",
                "orderSentence": "Baclofen 20 mg PO TID"
              },
              {
                "text": "20 mg QID",
                "orderSentence": "Baclofen 20 mg PO QID"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg TID; increase by 5 mg/dose q3d; max 80 mg/day",
            "orderSentence": "Baclofen 5 mg PO TID"
          },
          "contraindications": "Withdrawal risk if stopped abruptly; renal impairment",
          "monitoring": "Sedation; weakness; must taper to discontinue (seizure risk)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Disease-Specific / Immunotherapy": [
        {
          "item": "IVIg (intravenous immunoglobulin) (CPT 96365, 96366)",
          "route": "IV",
          "indication": "Severe/refractory neuralgic amyotrophy; diabetic amyotrophy (DLRPN) with vasculitic features; atypical inflammatory plexopathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg daily x5 days",
                "orderSentence": "Ivig 0.4 g/kg IV daily x5 days"
              },
              {
                "text": "1 g/kg daily x2 days",
                "orderSentence": "Ivig 1 g/kg IV daily x2 days"
              },
              {
                "text": "2 g/kg divided over 2-5 days",
                "orderSentence": "Ivig 2 g/kg IV divided over 2-5 days"
              }
            ],
            "route": "IV",
            "instructions": "0.4 g/kg/day IV x 5 days (total 2 g/kg); repeat q4 weeks x 3-6 months if responsive",
            "orderSentence": "Ivig 0.4 g/kg IV daily x5 days"
          },
          "contraindications": "IgA deficiency (anaphylaxis risk); renal insufficiency; hypercoagulable state",
          "monitoring": "Renal function; IgA level before first dose; infusion reaction vitals q15 min; headache (aseptic meningitis); thrombotic events",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Plasma exchange (PLEX) (CPT 36514)",
          "route": "IV",
          "indication": "Severe inflammatory plexopathy refractory to steroids and IVIg; CIDP-like plexopathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 exchanges",
                "orderSentence": "Plasma exchange (PLEX) (CPT 36514) 5 exchanges IV"
              }
            ],
            "route": "IV",
            "instructions": "5-7 exchanges over 10-14 days; 1-1.5 plasma volumes per exchange",
            "orderSentence": "Plasma exchange (PLEX) (CPT 36514) 5 exchanges IV"
          },
          "contraindications": "Hemodynamic instability; severe coagulopathy; poor IV access",
          "monitoring": "BP during exchange; electrolytes (Ca, K, Mg); fibrinogen; coags; line site infection",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT"
        },
        {
          "item": "Methotrexate",
          "route": "PO",
          "indication": "Steroid-sparing agent for chronic inflammatory plexopathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "7.5 mg weekly",
                "orderSentence": "Methotrexate 7.5 mg PO weekly"
              },
              {
                "text": "10 mg weekly",
                "orderSentence": "Methotrexate 10 mg PO weekly"
              },
              {
                "text": "15 mg weekly",
                "orderSentence": "Methotrexate 15 mg PO weekly"
              },
              {
                "text": "20 mg weekly",
                "orderSentence": "Methotrexate 20 mg PO weekly"
              },
              {
                "text": "25 mg weekly",
                "orderSentence": "Methotrexate 25 mg PO weekly"
              }
            ],
            "route": "PO",
            "instructions": "Start 7.5 mg weekly; increase by 2.5 mg q2-4 weeks; max 25 mg weekly; add folic acid 1 mg daily",
            "orderSentence": "Methotrexate 7.5 mg PO weekly"
          },
          "contraindications": "Pregnancy; severe hepatic/renal impairment; active infection; bone marrow suppression",
          "monitoring": "CBC, LFTs, creatinine q2-4 weeks x 3 months then q3 months; folic acid supplementation",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Azathioprine",
          "route": "PO",
          "indication": "Steroid-sparing agent for chronic relapsing plexopathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg daily",
                "orderSentence": "Azathioprine 50 mg PO daily"
              },
              {
                "text": "100 mg daily",
                "orderSentence": "Azathioprine 100 mg PO daily"
              },
              {
                "text": "150 mg daily",
                "orderSentence": "Azathioprine 150 mg PO daily"
              },
              {
                "text": "2-3 mg/kg daily",
                "orderSentence": "Azathioprine 2-3 mg/kg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 50 mg daily; titrate to 2-3 mg/kg/day over 4-6 weeks; check TPMT before starting",
            "orderSentence": "Azathioprine 50 mg PO daily"
          },
          "contraindications": "TPMT deficiency; pregnancy; concurrent allopurinol (dose reduction required)",
          "monitoring": "TPMT genotype before starting; CBC q2 weeks x 2 months then q3 months; LFTs",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Mycophenolate mofetil",
          "route": "PO",
          "indication": "Steroid-sparing for chronic inflammatory plexopathy (alternative)",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg BID",
                "orderSentence": "Mycophenolate Mofetil 500 mg PO BID"
              },
              {
                "text": "1000 mg BID",
                "orderSentence": "Mycophenolate Mofetil 1000 mg PO BID"
              },
              {
                "text": "1500 mg BID",
                "orderSentence": "Mycophenolate Mofetil 1500 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "Start 500 mg BID; increase to 1000 mg BID over 2-4 weeks; max 3000 mg/day",
            "orderSentence": "Mycophenolate Mofetil 500 mg PO BID"
          },
          "contraindications": "Pregnancy (teratogenic); active infection",
          "monitoring": "CBC q2 weeks x 3 months then monthly; GI symptoms; opportunistic infections",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Glycemic optimization (insulin/OHAs)",
          "route": "Variable",
          "indication": "Diabetic amyotrophy - tight glucose control is cornerstone of management",
          "dosing": {
            "doseOptions": [
              {
                "text": "Per protocol",
                "orderSentence": "Glycemic optimization (insulin/OHAs) Per protocol Variable"
              }
            ],
            "route": "Variable",
            "instructions": "Target HbA1c <7%; avoid rapid glucose reduction (risk of treatment-induced neuropathy if HbA1c drops >2% in 3 months)",
            "orderSentence": "Glycemic optimization (insulin/OHAs) Per protocol Variable"
          },
          "contraindications": "Hypoglycemia; individualize targets in elderly",
          "monitoring": "HbA1c q3 months; daily glucose monitoring; hypoglycemic events",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        }
      ],
      "Surgical/Procedural Treatments (Specialist Decision)": [
        {
          "item": "Surgical decompression of hematoma",
          "route": "Surgical",
          "indication": "Retroperitoneal hematoma compressing lumbosacral plexus; expanding hematoma despite reversal of anticoagulation",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Surgical decompression of hematoma N/A Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Emergent or urgent depending on progression; coordinate with vascular/general surgery",
            "orderSentence": "Surgical decompression of hematoma N/A Surgical"
          },
          "contraindications": "Uncontrolled coagulopathy (correct first); hemodynamic instability (stabilize first)",
          "monitoring": "Post-op neuro checks; coagulation status; hemoglobin; drain output",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Brachial plexus exploration and nerve repair (CPT 64713, 64856)",
          "route": "Surgical",
          "indication": "Traumatic brachial plexus injury with no recovery by 3-6 months; sharp/penetrating injuries (early repair)",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Brachial plexus exploration and nerve repair (CPT 64713, 64856) N/A Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Timing depends on mechanism: sharp injuries repair early (days-weeks); closed traction injuries explore at 3-6 months if no EMG recovery",
            "orderSentence": "Brachial plexus exploration and nerve repair (CPT 64713, 64856) N/A Surgical"
          },
          "contraindications": "Active infection; patient factors precluding prolonged surgery",
          "monitoring": "Post-op neuro exam; wound; serial EMG at 3-6 month intervals to assess reinnervation",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Nerve transfer (CPT 64905)",
          "route": "Surgical",
          "indication": "Proximal brachial plexus injury (root avulsion) where direct repair not possible",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Nerve transfer (CPT 64905) N/A Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Transfer of expendable donor nerve to target nerve; best results within 6-12 months of injury",
            "orderSentence": "Nerve transfer (CPT 64905) N/A Surgical"
          },
          "contraindications": "Active infection; poor donor nerve options; extensive pan-plexus injury",
          "monitoring": "Serial clinical and EMG evaluation; recovery takes 6-18 months",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Nerve graft (CPT 64910)",
          "route": "Surgical",
          "indication": "Gap in nerve continuity after traumatic injury or tumor resection",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Nerve graft (CPT 64910) N/A Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Sural nerve or other donor nerve graft to bridge gap; best results with gaps <6 cm",
            "orderSentence": "Nerve graft (CPT 64910) N/A Surgical"
          },
          "contraindications": "Active infection; severe medical comorbidities; poor regenerative potential",
          "monitoring": "Serial EMG; clinical exam q3 months; donor site sensory deficit expected",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Tumor resection",
          "route": "Surgical",
          "indication": "Neoplastic plexopathy - resectable tumor compressing plexus",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Tumor resection N/A Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Coordinate with oncology and nerve surgery; intraoperative monitoring recommended",
            "orderSentence": "Tumor resection N/A Surgical"
          },
          "contraindications": "Unresectable tumor (radiation instead); poor surgical candidate",
          "monitoring": "Post-op neuro exam; oncology follow-up; adjuvant therapy per oncology",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Radiation therapy",
          "route": "External beam",
          "indication": "Neoplastic plexopathy (Pancoast tumor, lymphoma, metastatic disease)",
          "dosing": {
            "doseOptions": [
              {
                "text": "Per protocol",
                "orderSentence": "Radiation therapy Per protocol External beam"
              }
            ],
            "route": "External beam",
            "instructions": "Dose and fractionation per tumor type and radiation oncology plan",
            "orderSentence": "Radiation therapy Per protocol External beam"
          },
          "contraindications": "Prior radiation to same field (cumulative dose limits); pregnancy",
          "monitoring": "Radiation plexopathy monitoring (may develop months-years later); skin integrity; CBC",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Epidural steroid injection / nerve root block (CPT 64483)",
          "route": "Fluoroscopic",
          "indication": "Plexopathy with concurrent radicular component; diagnostic block to differentiate radiculopathy from plexopathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "Per protocol",
                "orderSentence": "Epidural steroid injection / nerve root block (CPT 64483) Per protocol Fluoroscopic"
              }
            ],
            "route": "Fluoroscopic",
            "instructions": "Fluoroscopic-guided transforaminal approach; diagnostic and therapeutic",
            "orderSentence": "Epidural steroid injection / nerve root block (CPT 64483) Per protocol Fluoroscopic"
          },
          "contraindications": "Coagulopathy (INR >1.5, plt <100k); infection at site; allergy to contrast/steroids",
          "monitoring": "Post-procedure neuro exam; glucose (diabetics); headache",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology consult for all suspected plexopathy (confirmation of diagnosis, localization, etiology determination)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "EMG/NCS referral for electrodiagnostic confirmation and localization (optimal timing 3-4 weeks after onset; earlier if needed for baseline)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Oncology consult STAT for suspected neoplastic plexopathy (Pancoast tumor, pelvic malignancy, lymphoma)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "URGENT",
          "ICU": "STAT"
        },
        {
          "item": "Surgical consult (neurosurgery or peripheral nerve surgery) for traumatic plexopathy with no recovery, expanding hematoma, or nerve repair candidacy",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Radiation oncology consult for radiation-induced plexopathy management and for neoplastic plexopathy treatment",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Pain management/Interventional pain for refractory neuropathic pain; nerve blocks; neuromodulation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Endocrinology for diabetic amyotrophy (glycemic optimization and diabetic complication management)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Rheumatology for suspected vasculitic plexopathy (systemic vasculitis workup and immunosuppressive management)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Physical therapy for shoulder/hip stabilization, progressive strengthening, ROM maintenance, and adaptive equipment training",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Occupational therapy for upper extremity plexopathy (ADL training, splinting, adaptive devices, ergonomic modifications)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "PM&R (Physical Medicine & Rehabilitation) for comprehensive neurorehabilitation program",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Vascular surgery consult if vascular injury suspected (traumatic plexopathy with limb ischemia)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Psychology/Pain psychology for chronic pain management, coping strategies, CBT for neuropathic pain",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Social work for disability assistance, return-to-work planning, and insurance navigation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Patient Instructions": [
        {
          "item": "Return to ED IMMEDIATELY if rapid worsening of weakness, loss of ability to use arm/hand or walk, or new bowel/bladder dysfunction",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Return to ED if fever develops with worsening neurological symptoms (may indicate infection)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Return if new onset of drooping eyelid with arm weakness (Horner syndrome - may indicate Pancoast tumor)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Parsonage-Turner syndrome (neuralgic amyotrophy) has a prolonged recovery course (months to 2-3 years); improvement is expected but slow",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Protect the weak limb from injury: avoid carrying heavy objects with affected arm; use assistive devices for walking if leg is weak",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "For shoulder plexopathy: avoid sleeping on the affected side; use a sling only as directed (prolonged sling use causes frozen shoulder)",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Perform prescribed physical therapy exercises daily at home to maintain range of motion and prevent contractures",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Do not stop gabapentin/pregabalin abruptly - taper under medical guidance to avoid withdrawal",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Neuropathic pain medications (gabapentin, pregabalin, duloxetine) take 2-4 weeks to reach full effect; do not stop prematurely",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "If diabetic: tight glucose control is essential for recovery; monitor blood sugars as directed and follow up with endocrinology",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report any new lumps, unexplained weight loss, or night sweats to your physician (may indicate malignancy)",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Do not drive while taking opioids or sedating medications",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Follow up with neurology in 2-4 weeks for clinical and EMG reassessment",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Smoking cessation to improve nerve healing and reduce vascular risk (smoking impairs peripheral nerve regeneration)",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Weight management to reduce mechanical stress on plexus and improve surgical outcomes if needed",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Glycemic control if diabetic (HbA1c <7%) to prevent diabetic amyotrophy recurrence and facilitate nerve recovery",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid rapid glucose reduction (HbA1c drop >2% in 3 months) which can paradoxically worsen neuropathy (treatment-induced neuropathy of diabetes)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Ergonomic workstation modifications if plexopathy affects work capacity; adjustable desk, ergonomic keyboard",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "Use shoulder/arm sling as directed for brachial plexopathy but remove regularly for ROM exercises to prevent frozen shoulder",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid repetitive overhead activities during recovery from brachial plexopathy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Fall prevention measures if lower extremity weakness present (remove loose rugs, install grab bars, use assistive devices)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Maintain range of motion with daily passive and active exercises to prevent contractures",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Adequate nutrition (protein, vitamin B complex) to support nerve regeneration",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Manage stress and ensure adequate sleep as chronic pain worsens with fatigue and stress",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Alcohol moderation (excessive alcohol impairs nerve regeneration and compounds neuropathy risk)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Cervical radiculopathy",
      "features": "Dermatomal distribution (single root); neck pain with Spurling test positive; symptoms follow one root territory",
      "tests": "MRI cervical spine shows disc/foraminal pathology; EMG limited to one myotome; no abnormal SNAP (pre-ganglionic)"
    },
    {
      "diagnosis": "Lumbar radiculopathy",
      "features": "Dermatomal distribution; positive straight leg raise; back pain radiating in single root territory",
      "tests": "MRI lumbar spine shows disc herniation/stenosis; EMG limited to one myotome"
    },
    {
      "diagnosis": "Mononeuropathy (single nerve)",
      "features": "Deficit restricted to single nerve territory (e.g., axillary, suprascapular, femoral, obturator)",
      "tests": "EMG/NCS isolated to single nerve; plexopathy affects multiple nerves from same plexus"
    },
    {
      "diagnosis": "Rotator cuff tear",
      "features": "Shoulder pain with weakness in specific rotator cuff muscles; positive impingement signs",
      "tests": "MRI shoulder shows tendon tear; EMG normal (no denervation)"
    },
    {
      "diagnosis": "Cervical myelopathy",
      "features": "Upper motor neuron signs (hyperreflexia, Babinski, spasticity); gait ataxia; bilateral symptoms",
      "tests": "MRI cervical spine shows cord compression/signal change; EMG may be normal"
    },
    {
      "diagnosis": "Polymyositis/Dermatomyositis",
      "features": "Proximal symmetric weakness; elevated CK; skin changes (dermatomyositis); no sensory loss",
      "tests": "Elevated CK; EMG shows myopathic pattern; muscle biopsy; myositis-specific antibodies"
    },
    {
      "diagnosis": "Motor neuron disease (ALS)",
      "features": "Progressive weakness without sensory loss; upper + lower motor neuron signs; fasciculations",
      "tests": "EMG shows widespread denervation in multiple regions; no sensory nerve abnormalities"
    },
    {
      "diagnosis": "Multifocal motor neuropathy (MMN)",
      "features": "Asymmetric distal > proximal weakness; no sensory loss; slowly progressive",
      "tests": "NCS shows conduction block; anti-GM1 IgM antibodies; responds to IVIg"
    },
    {
      "diagnosis": "CIDP",
      "features": "Symmetric proximal and distal weakness; areflexia; sensory loss; progressive >8 weeks",
      "tests": "NCS shows demyelinating pattern; CSF elevated protein; nerve biopsy shows demyelination"
    },
    {
      "diagnosis": "Guillain-Barre syndrome",
      "features": "Ascending weakness; areflexia; often post-infectious; acute onset (<4 weeks)",
      "tests": "NCS shows demyelinating or axonal pattern; CSF albuminocytologic dissociation"
    },
    {
      "diagnosis": "Vasculitic neuropathy",
      "features": "Mononeuritis multiplex pattern (stepwise); systemic symptoms; weight loss; rash",
      "tests": "ESR/CRP elevated; ANCA positive; nerve biopsy shows necrotizing vasculitis"
    },
    {
      "diagnosis": "Hereditary neuropathy (HNPP)",
      "features": "Recurrent pressure palsies; family history; generalized slowing on NCS",
      "tests": "NCS shows diffuse conduction slowing; genetic testing (PMP22 deletion); tomaculous neuropathy on biopsy"
    },
    {
      "diagnosis": "Thoracic outlet syndrome",
      "features": "Positional arm symptoms (overhead); vascular compromise (venous, arterial); neurogenic TOS rare",
      "tests": "Provocative maneuvers (Adson, Wright); NCS (medial antebrachial cutaneous SNAP reduced); MRA/MRV"
    },
    {
      "diagnosis": "Meralgia paresthetica",
      "features": "Isolated lateral thigh numbness/burning (lateral femoral cutaneous nerve); no weakness",
      "tests": "Normal EMG; abnormal lateral femoral cutaneous NCS; MRI plexus normal"
    },
    {
      "diagnosis": "Lumbosacral radiculoplexus neuropathy (non-diabetic)",
      "features": "Identical to diabetic amyotrophy but in non-diabetic; weight loss; severe pain",
      "tests": "EMG shows lumbosacral plexopathy; nerve biopsy: microvasculitis; HbA1c normal"
    },
    {
      "diagnosis": "Cauda equina syndrome",
      "features": "Saddle anesthesia; bowel/bladder dysfunction; bilateral leg symptoms",
      "tests": "MRI shows large central disc or mass compressing cauda equina"
    },
    {
      "diagnosis": "Spinal cord tumor",
      "features": "Progressive myelopathic symptoms; pain worse at night; specific level on exam",
      "tests": "MRI with contrast shows enhancing intramedullary or extramedullary mass"
    },
    {
      "diagnosis": "Retroperitoneal mass (non-neoplastic)",
      "features": "Compressive lumbosacral plexopathy from abscess, fibrosis, endometriosis, aneurysm",
      "tests": "CT/MRI pelvis shows structural cause; ESR/CRP if infectious; biopsy if mass"
    }
  ],
  "evidence": [
    {
      "recommendation": "Neuralgic amyotrophy is the most common non-traumatic brachial plexopathy; annual incidence 1-3/100,000",
      "evidenceLevel": "Class II, Level B",
      "source": "[van Alfen N, van Engelen BG. Brain 2006](https://pubmed.ncbi.nlm.nih.gov/16371410/)"
    },
    {
      "recommendation": "MRI with STIR sequences is essential for plexus evaluation; detects denervation muscle edema and nerve signal abnormalities",
      "evidenceLevel": "Class II, Level B",
      "source": "Stable-Delma A et al. Skeletal Radiol 2021"
    },
    {
      "recommendation": "EMG/NCS is the gold standard for confirming and localizing plexopathy; optimal timing 3-4 weeks post-onset",
      "evidenceLevel": "Class I, Level A",
      "source": "[Ferrante MA. Continuum (Minneap Minn) 2014](https://pubmed.ncbi.nlm.nih.gov/25299285/)"
    },
    {
      "recommendation": "Diabetic lumbosacral radiculoplexus neuropathy (DLRPN) is caused by microvasculitis; immunotherapy may help",
      "evidenceLevel": "Class II, Level B",
      "source": "[Dyck PJ et al. Neurology 1999](https://pubmed.ncbi.nlm.nih.gov/10599791/)"
    },
    {
      "recommendation": "IVIg did not show significant benefit over placebo in DLRPN in a randomized trial but may help selected severe cases",
      "evidenceLevel": "Class I, Level B",
      "source": "Dyck PJB et al. Neurology 2006"
    },
    {
      "recommendation": "Corticosteroids are commonly used for acute neuralgic amyotrophy but evidence is limited to retrospective/observational data",
      "evidenceLevel": "Class III, Level C",
      "source": "[van Eijk JJ, van Alfen N et al. J Neurol Neurosurg Psychiatry 2009](https://pubmed.ncbi.nlm.nih.gov/19321467/)"
    },
    {
      "recommendation": "Radiation-induced plexopathy: myokymic discharges on EMG are pathognomonic; differentiates from tumor recurrence",
      "evidenceLevel": "Class II, Level B",
      "source": "[Harper CM Jr et al. Neurology 1989](https://pubmed.ncbi.nlm.nih.gov/2538777/)"
    },
    {
      "recommendation": "PET-CT helps differentiate radiation plexopathy from tumor recurrence (FDG-avid suggests recurrence)",
      "evidenceLevel": "Class II, Level B",
      "source": "Basu S et al. Mol Imaging Biol 2011"
    },
    {
      "recommendation": "Gabapentin/pregabalin are first-line for neuropathic pain including plexopathy-related neuropathic pain",
      "evidenceLevel": "Class I, Level A",
      "source": "[Finnerup NB et al. Lancet Neurol 2015](https://pubmed.ncbi.nlm.nih.gov/25575710/)"
    },
    {
      "recommendation": "Early nerve repair (within 6 months) for traumatic brachial plexus injury improves outcomes",
      "evidenceLevel": "Class II, Level B",
      "source": "[Terzis JK, Kostopoulos VK. Plast Reconstr Surg 2007](https://pubmed.ncbi.nlm.nih.gov/17496583/)"
    },
    {
      "recommendation": "Nerve transfer procedures improve functional outcomes for proximal brachial plexus injuries with root avulsion",
      "evidenceLevel": "Class II, Level B",
      "source": "[Bertelli JA, Ghizoni MF. J Neurosurg 2004](https://pubmed.ncbi.nlm.nih.gov/15540915/)"
    },
    {
      "recommendation": "Tight glycemic control is cornerstone of management for diabetic amyotrophy; avoid rapid HbA1c reduction >2% in 3 months",
      "evidenceLevel": "Class II, Level B",
      "source": "[Gibbons CH, Freeman R. Brain 2015](https://pubmed.ncbi.nlm.nih.gov/25392197/)"
    },
    {
      "recommendation": "Hereditary neuralgic amyotrophy (SEPT9 mutations) in recurrent episodes or family history",
      "evidenceLevel": "Class III, Level C",
      "source": "[Kuhlenbumer G et al. Nat Genet 2005](https://pubmed.ncbi.nlm.nih.gov/16186812/)"
    },
    {
      "recommendation": "Duloxetine is effective for diabetic neuropathic pain and benefits plexopathy-related neuropathic pain",
      "evidenceLevel": "Class I, Level A",
      "source": "[Lunn MPT et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/24385423/)"
    },
    {
      "recommendation": "Retroperitoneal hematoma causing lumbosacral plexopathy requires urgent CT and anticoagulation reversal",
      "evidenceLevel": "Class III, Level C",
      "source": "Patel A et al. Am J Emerg Med 2019"
    },
    {
      "recommendation": "Physical therapy and occupational therapy improve functional outcomes in plexopathy rehabilitation",
      "evidenceLevel": "Class II, Level B",
      "source": "Merrell GA et al. Hand Clin 2005"
    }
  ],
  "monitoring": [
    {
      "item": "Motor strength (MRC grading)",
      "frequency": "Each visit; weekly if inpatient",
      "action": "Progressive weakness: repeat imaging; escalate immunotherapy; surgical consult",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "STAT"
    },
    {
      "item": "Pain scores (0-10 NRS)",
      "frequency": "Each visit",
      "action": "Escalate neuropathic pain regimen; interventional pain referral",
      "ED": "ROUTINE",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "ROUTINE"
    },
    {
      "item": "Sensory exam (plexus distribution)",
      "frequency": "Each visit",
      "action": "Document progression; correlate with repeat EMG",
      "ED": "ROUTINE",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "ROUTINE"
    },
    {
      "item": "Deep tendon reflexes",
      "frequency": "Each visit",
      "action": "New hyperreflexia suggests central lesion: MRI spine",
      "ED": "ROUTINE",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "ROUTINE"
    },
    {
      "item": "EMG/NCS follow-up",
      "frequency": "Baseline (3-4 weeks), then q3-6 months",
      "action": "No reinnervation by 3-6 months in traumatic: surgical exploration",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Repeat MRI plexus",
      "frequency": "3-6 months or if clinical change",
      "action": "New or enlarging mass: biopsy; escalate treatment",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "HbA1c (diabetic amyotrophy)",
      "frequency": "q3 months",
      "action": "Adjust diabetes management; endocrinology optimization",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "CBC/LFTs (if on immunosuppression)",
      "frequency": "q2-4 weeks initially, then q3 months",
      "action": "Leukopenia or elevated LFTs: hold or reduce immunosuppressant; hematology consult",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Renal function (if on NSAIDs >2 weeks)",
      "frequency": "Baseline, then q3 months",
      "action": "Decline: discontinue NSAIDs; switch to acetaminophen/other",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Glucose (if on steroids)",
      "frequency": "Daily if inpatient; before/after procedures",
      "action": "Adjust diabetes medications; limit steroid duration",
      "ED": "ROUTINE",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "ROUTINE"
    },
    {
      "item": "Functional status (grip strength, timed walk, disability scales)",
      "frequency": "Baseline, 6 weeks, 3 months, 6 months, 12 months",
      "action": "Not improving: reassess treatment; surgical options; adjust rehabilitation",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Respiratory function (if phrenic nerve involved - C3-C5)",
      "frequency": "Each visit if suspected",
      "action": "Declining FVC: pulmonology consult; sleep study for nocturnal desaturation; phrenic nerve pacing",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "ROUTINE"
    }
  ],
  "disposition": [
    {
      "disposition": "Discharge home",
      "criteria": "Pain controlled with oral medications; stable or slowly improving neurologic exam; no red flags; able to perform basic ADLs (possibly with modifications); reliable outpatient follow-up with neurology in 2-4 weeks; physical/occupational therapy arranged"
    },
    {
      "disposition": "Admit to floor",
      "criteria": "Severe pain requiring IV analgesia; rapidly progressive weakness requiring close monitoring; need for IV immunotherapy (IVIg, methylprednisolone pulse); suspected neoplastic plexopathy requiring urgent workup; suspected retroperitoneal hematoma; inability to perform basic ADLs safely"
    },
    {
      "disposition": "Admit to ICU",
      "criteria": "Respiratory compromise from phrenic nerve involvement (bilateral brachial plexopathy); hemodynamic instability from retroperitoneal hemorrhage; post-surgical monitoring after complex plexus surgery; concurrent autonomic instability"
    },
    {
      "disposition": "Emergent surgery consult",
      "criteria": "Expanding retroperitoneal hematoma with progressive lumbosacral plexopathy; traumatic plexopathy with vascular compromise; acute nerve compression from hematoma or abscess"
    },
    {
      "disposition": "Transfer to higher level",
      "criteria": "Peripheral nerve surgery expertise not available; MR neurography/dedicated plexus imaging not available; need for specialized EMG by neuromuscular specialist not available locally"
    }
  ]
}
